Page 35 - Coronavirus Vaccine

Covid: Delhi sees nearly two-fold rise in hospitalisations in a fortnight

Amid a spike in COVID-19 cases in the national capital, there has been a nearly two-fold increase in hospitalisations in over a fortnight, with officials saying those with comorbidities are getting admitted to hospitals. Even though the rise in infections and hospitalisations is not yet alarming, experts have reiterated the need to wear masks and follow Covid-appropriate behaviour. Of the 9,405 available beds for coronavirus patients in Delhi, 307 (3.26 per cent) were occupied on August 1. The occupancy rate was 3.75 per cent on August 2 and four per cent the day after. It kept on rising on most days thereafter and stood at 6.24 per cent on August 16. The bed occupancy rate was five per cent on August 6 and 5.97 per cent on August 11. The occupancy rate was 6.13 per cent on August 12 and declined marginally to 5.99 per cent the next day. It rose to 6.21 per cent on August 14 and stood at 6.31 per cent on August 15. Dr Vikas Maurya, Director and HOD, Pulmonology, Fortis Hospital ...

Only 10% of hospitalised Covid patients have taken precaution dose: Sisodia

'It is clear that people who apply precautionary doses are safer from coronavirus infection,' says Delhi Deputy Chief Minister

Data story: India adds 14,917 new Covid cases, active tally at 117,508

India on August 15 reported an increase of 647 in active coronavirus cases to take its count to 117,508

India at 75: PM Narendra Modi sets road map for developed India by 2047

Launches frontal attack on corruption and nepotism

Bharat Biotech says Phase 3 trial over, intranasal vaccine 'safe'

The Hyderabad-based company claimed that BBV154 is proven to be safe, well-tolerated and immunogenic in the subjects under controlled clinical trials

Moderna's Omicron-adapted Covid vaccine wins first approval in Britain

The UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by the US drug company Moderna as a booster for adults

India likely to get Omicron-specific vaccine by year-end, says SII chief

SII is working with Novavax to bring the Omicron-specific vaccine, as the nation continues to record a surge in the number of Covid-19 cases

Covid intranasal vaccine Phase III trials over, proven safe: Bharat Biotech

BBV154 was developed in partnership with Washington Univ St Louis, which had designed and developed recombinant adenoviral vectored constructs and evaluated them in preclinical studies for efficacy

Coronavirus update: India logs 14,092 Covid cases, 41 deaths in 24 hours

India reported 14,092 new Covid cases in the last 24 hours, a marginal decline from the previous day's count of 15,815 Covid, said the Union Health Ministry on Sunday

Data story: India adds 15,815 new Covid cases, 68 deaths in 24 hours

India has so far administered 2,077,162,098 vaccine doses

SC to hear plea of IMA on campaign against vaccination, modern medicines

A bench of CJI, Justice Krishna Murari was told that a concerted effort is being made to discourage vaccinations, including the COVID-19 jab drive, and the use of allopathic medicines in the country.

Data story: India adds 16,561 new Covid cases, death toll at 526,928

India has added 115,969 cases in the past 7 days

J&J Covid vaccine factory forced to trash nearly 135 mn more doses

About 135 million more doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory will have to be destroyed due to quality problems, Congressional panel leaders said Thursday. The announcement follows a report in May that detailed how more than 400 million vaccine doses made at an Emergent BioSolutions plant had to be trashed. The doses more recently slated for destruction were made between August 2021 and February, the House members said. Johnson & Johnson said in a statement Thursday that no doses produced at the site since the factory restarted have reached the market, and it was ending its agreement with Emergent. The doses had been set aside after they were made. The panel said J&J told it that a batch of the shots failed inspection, which rendered all of them unusable. The factory's problems have hurt vaccinations in areas of the world where vaccines are still in short supply, said US Rep. Jim Clyburn, a South Carolina Democrat and COVID-19 ...

Covid: 100 mn doses of Corbevax supplied to Centre, says Biological E

Corbevax is expected to be available as a booster dose on the CoWIN App in public and private vaccination centres from August 12

Indian Covid vaccine makers eye regulator nod for universal boosters

Plans afoot to seek regulator nod for universal boosters

Delhi to strictly enforce mask fines in view of surge in Covid cases

The South Delhi district magistrate has formed three teams for enforcement of wearing face masks in public places

Corbevax approved as booster for adults vaccinated with Covaxin, Covishield

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday

'Global flyers may not be required to upload vax certificate on Suvidha'

The existing mandate of filling up a self-declaration form online on the portal will continue, official sources told PTI.

Govt nod for Corbevax as booster for vaccinated adults soon: Report

If approved by the government, this would be the first time a booster dose of a Covid vaccine different from the one used for primary vaccination would be allowed in the country.

Covid: Telangana govt urges Centre to provide 5 mn doses of Covishield

Health Minister T. Harish Rao said Telangana has potential to administer over 3 lakh precautionary doses per day, which is not being realised due to a shortage of vaccines, particularly Covishield.